JP2011521967A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011521967A5 JP2011521967A5 JP2011511835A JP2011511835A JP2011521967A5 JP 2011521967 A5 JP2011521967 A5 JP 2011521967A5 JP 2011511835 A JP2011511835 A JP 2011511835A JP 2011511835 A JP2011511835 A JP 2011511835A JP 2011521967 A5 JP2011521967 A5 JP 2011521967A5
- Authority
- JP
- Japan
- Prior art keywords
- immune
- cells
- target
- immune system
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000000987 immune system Anatomy 0.000 claims 3
- 210000003719 b-lymphocyte Anatomy 0.000 claims 2
- 210000001239 CD8-positive, alpha-beta cytotoxic T lymphocyte Anatomy 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 210000002443 helper t lymphocyte Anatomy 0.000 claims 1
- 210000001165 lymph node Anatomy 0.000 claims 1
- 210000002540 macrophage Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5692508P | 2008-05-29 | 2008-05-29 | |
| US61/056,925 | 2008-05-29 | ||
| PCT/US2009/045550 WO2009146392A1 (en) | 2008-05-29 | 2009-05-29 | Mechanism of action of primary cell derived biologic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011521967A JP2011521967A (ja) | 2011-07-28 |
| JP2011521967A5 true JP2011521967A5 (enExample) | 2012-11-01 |
Family
ID=41377590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011511835A Withdrawn JP2011521967A (ja) | 2008-05-29 | 2009-05-29 | 初代細胞由来生物製剤の作用機序 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110081313A1 (enExample) |
| EP (1) | EP2296704A4 (enExample) |
| JP (1) | JP2011521967A (enExample) |
| AU (1) | AU2009251277A1 (enExample) |
| CA (1) | CA2762314A1 (enExample) |
| MX (1) | MX2010012985A (enExample) |
| WO (1) | WO2009146392A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070154399A1 (en) * | 2000-10-27 | 2007-07-05 | Hadden John W | Immunotherapy for immune suppressed patients |
| US20070025958A1 (en) * | 2000-10-27 | 2007-02-01 | Hadden John W | Vaccine immunotherapy |
| MXPA03003638A (es) | 2000-10-27 | 2004-01-26 | Immuno Rx Inc | Inmunoterapia con vacuna para pacientes inmunosuprimidos. |
| ES2653887T3 (es) | 2007-11-28 | 2018-02-09 | Irx Therapeutics, Inc. | Procedimiento para aumentar el efecto inmunológico |
| JP5797190B2 (ja) | 2009-05-15 | 2015-10-21 | アイ アール エックス セーラピューティクス， インコーポレイテッド | ワクチン免疫療法 |
| CN107050430B (zh) | 2009-12-08 | 2021-10-15 | 伊尔克斯治疗有限公司 | 逆转朗格汉斯细胞免疫抑制的方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6667175B1 (en) * | 1999-06-15 | 2003-12-23 | The Trustees Of Columbia University | Generation of antigen specific T suppressor cells for treatment of rejection |
| US20070031372A1 (en) * | 2004-08-05 | 2007-02-08 | Hadden John W | Vaccine immunotherapy for immune suppressed patients |
| US20070025958A1 (en) * | 2000-10-27 | 2007-02-01 | Hadden John W | Vaccine immunotherapy |
| MXPA03003638A (es) | 2000-10-27 | 2004-01-26 | Immuno Rx Inc | Inmunoterapia con vacuna para pacientes inmunosuprimidos. |
| WO2005120550A2 (en) * | 2004-06-04 | 2005-12-22 | Cel-Sci Corporation | A method for altering the cd4/cd8 ratio and the mononuclear cellular infiltrate into a tumor |
| US20060140983A1 (en) * | 2004-10-25 | 2006-06-29 | Baylor Research Institute | Dendritic cells loaded with heat shocked melanoma cell bodies |
| ITMI20051209A1 (it) | 2005-06-27 | 2006-12-28 | Tecnosanimed S R L | Metodo per la predisposizione di set procedurali sterili di strumenti chirurgici per il servizio alle sale operatorie e trattamento di sanificazione tracciabile di sanificazione manutenzione confezionamento e sterilizzazione |
| AU2006292203A1 (en) * | 2005-09-21 | 2007-03-29 | Dask Technologies, Llc | Methods and compositions for organ and tissue functionality |
| ES2653887T3 (es) * | 2007-11-28 | 2018-02-09 | Irx Therapeutics, Inc. | Procedimiento para aumentar el efecto inmunológico |
-
2009
- 2009-05-29 US US12/995,054 patent/US20110081313A1/en not_active Abandoned
- 2009-05-29 JP JP2011511835A patent/JP2011521967A/ja not_active Withdrawn
- 2009-05-29 MX MX2010012985A patent/MX2010012985A/es not_active Application Discontinuation
- 2009-05-29 AU AU2009251277A patent/AU2009251277A1/en not_active Abandoned
- 2009-05-29 EP EP09755753A patent/EP2296704A4/en not_active Withdrawn
- 2009-05-29 CA CA2762314A patent/CA2762314A1/en not_active Abandoned
- 2009-05-29 WO PCT/US2009/045550 patent/WO2009146392A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2013001602A1 (es) | Metodo para reducir o inhibir la progresion del nivel de fatiga en pacientes con esclerosis multiple y para proporcionarles neuroproteccion que comprende administrar oralmente laquinimod o una sal del mismo; laquinimod para reducir el nivel de fatiga, mejorar el estado funcional y entregar neuroproteccion en esclerosis multiple. | |
| HK1205453A1 (en) | Methods of diagnosing and treating motor neuron diseases | |
| JP2011521967A5 (enExample) | ||
| CL2013003341A1 (es) | Un metodo y sistema para autenticar una sesion de un usuario. | |
| JP2012143233A5 (enExample) | ||
| JP2011511805A5 (enExample) | ||
| JP2011136997A5 (enExample) | ||
| JP2007509067A5 (enExample) | ||
| JP2013005803A5 (enExample) | ||
| JP2013527965A5 (enExample) | ||
| JP2012500090A5 (enExample) | ||
| MX388743B (es) | Conjugados oligonucleótido-péptido. | |
| WO2010037395A3 (en) | Mhc multimers in cancer vaccines and immune monitoring | |
| HK1200321A1 (en) | Bispecific immunobinders directed against tnf and il-17 | |
| EP2713732A4 (en) | PIRFENIDONE AND ANTIFIBROSETHERAPY IN SELECTED PATIENTS | |
| JP2011522896A5 (enExample) | ||
| EA201001771A1 (ru) | Лечение релаксином одышки, ассоциированной с острой сердечной недостаточностью | |
| JP2014530840A5 (enExample) | ||
| GT201500046A (es) | Mètodos para el tratamiento de infecciones de hepatitis b y hepatitis d | |
| BRPI1008517A2 (pt) | direcionamento duplo de mir-208 e mir-499 no tratamento de doenças cardíacas. | |
| CL2012001999A1 (es) | Material resistente a la formacion de biopelicula que comprende un agente activo compuesto esencialmente de un oxido de cobre insoluble a una concentracion de entre 3 y 10 % de dicho material resistente a la formacion de biopelicula; y metodo de prevencion, disminucion de incidencia formacion biopeliculas. | |
| BR112014009789A2 (pt) | cisteamina no tratamento da doença fibrótica | |
| PL2859092T3 (pl) | Szczepionka terapeutyczna do leczenia cukrzycy typu 1 u dzieci, zastosowanie sortera komórek oraz sposób namnażania komórek Treg do wytwarzania szczepionki do leczenia cukrzycy typu 1 | |
| CL2013000202A1 (es) | Composicion farmaceutica y combinacion compuesta por una forma potenciada activada de un anticuerpo contra la bradiquinina, una forma potenciada activada de una histamina y una forma potenciada activada de un anticuerpo contra la morfina; metodos para tratar las enfermedades o las condiciones asociadas con la enfermedad o condicion respiratoria. | |
| SG11201600933QA (en) | Application of andrographolide in the preparation of a pharmaceutical for treatment of inflammatory bowel disease, andrographolide enteric targeting micropellet, and method for preparation thereof |